Figure 2From: Strategy Escalation: An emerging paradigm for safe clinical development of T cell gene therapiesOptimal pathways for Strategy Escalation. All paths to 2nd generation engrafted ("4") pass through a full prior test of 2nd generation infused ("3"). See text.Back to article page